Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • Cordis’ sirolimus drug-coated balloon earns FDA approval as a breakthrough device

Cordis’ sirolimus drug-coated balloon earns FDA approval as a breakthrough device

September 22, 2026Posted inMedical Technology

The FDA gave the green light to a first and only sirolimus drug-eluting balloon designed by Cordis to treat coronary in-stent restenosis.

Post navigation

Previous Post
Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes
Next Post
Siemens Healthineers and Novo team up on fatty liver disease awareness, testing

Recent Posts

  • Farmers’ Knowledge and Field Science Agree on How to Save Ethiopia’s Rangelands
  • Scientists Find Urine Biomarkers That Reveal Which Children Need Kidney Surgery
  • Muscle-Mimicking Conductive Hydrogel Offers New Hope for Pelvic Organ Prolapse Repair
  • Tirzepatide Eases Sleep Apnea Across All Patient Types, Landmark Post Hoc Analysis Shows
  • Humpback Whale Mother Keeps Vigil Beside Her Stillborn Calf

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top